Nyheter
Much ado about nothing
Neuroreader® – MRI volumetric analysis Software Is reliable, actionable and timesaving In as little as 10 minutes 45 of the
With Eliq, you can empower your customers with precise energy insights and offer tailored, relevant advice to enable energy savings. You can achieve over 80% accuracy on energy insights, awareness, and actions – even without smart meter access. Enhance your customers’ understanding of their energy consumption by proactively notifying and advising them on ways to improve energy efficiency and save energy.
With Eliq, you can empower your customers with precise energy insights and offer tailored, relevant advice to enable energy savings. You can achieve over 80% accuracy on energy insights, awareness, and actions – even without smart meter access. Enhance your customers’ understanding of their energy consumption by proactively notifying and advising them on ways to improve energy efficiency and save energy.
It’s no secret that happier customers stay longer. But what if you could not only keep your customers happy but also be their trusted partner on their home energy efficiency journey? Personal energy insights reduce the need for calls and one-to-one customer service, everybody wins!
Help your customers with their home energy data management, and enable them to save both energy and money. When customers get a clear picture of their energy spending and future forecasts, it opens up possibilities for making home energy upgrades or finding ways to save.
With stronger customer relationships and boosted engagement, utility providers are able to explore revenue opportunities beyond commodities – like personalised recommendations for home energy upgrades. Customers can make informed decisions and complete energy efficiency investments, for a greener home.
We make use of molecules for tissue repair in the same way the body does!
Woundcom, our wound dressing under development, harnesses the power of collagen-based technology to promote efficient tissue repair, offering a solution for challenging tissue disruptions and at the same time preventing bacterial growth.
The WOUNDCOM project was initially developed at Lund University and under Swedish law, all rights to the project belonged to the inventors who co-founded Colzyx. All the rights to present and future inventions related to the original invention have been transferred to the company. Colzyx filed a PCT application titled “Novel polypeptides and medical uses thereof” that became public in July 2017 (WO2017125585A3). Further patent applications have been filed in order to develop the intellectual property rights associated with molecules derived from human Collagen VI and the application of these.
The WOUNDCOM project was initially developed at Lund University and under Swedish law, all rights to the project belonged to the inventors who co-founded Colzyx. All the rights to present and future inventions related to the original invention have been transferred to the company. Colzyx filed a PCT application titled “Novel polypeptides and medical uses thereof” that became public in July 2017 (WO2017125585A3). Further patent applications have been filed in order to develop the intellectual property rights associated with molecules derived from human Collagen VI and the application of these.
Early detection of neurodegenerative diseases is often the first step in improving quality of life for patients.
Our flagship product, Neuroreader®, is a ground-breaking, FDA-cleared, and CE-marked medical device that uses MRI scans to detect anomalous brain patterns in a fraction of time needed for manual segmentation — one of the current “gold standards” of neurodegenerative disease detection.
Is reliable, actionable and timesaving
In as little as 10 minutes 45 of the most important brain structures are quantified.
The accurate data Neuroreader® provides can benefit the optimization of treatment.
Adds value
Quantitative volumetric imaging adds substantial diagnostic value to neuroimaging by providing objective evaluation of the MRI findings.
Incorporates easily into workflow
Neuroreader® is easy to add on to any routine MRI of the brain and to any existing workflow.
Early detection of neurodegenerative diseases is often the first step in improving quality of life for patients.
Our flagship product, Neuroreader®, is a ground-breaking, FDA-cleared, and CE-marked medical device that uses MRI scans to detect anomalous brain patterns in a fraction of time needed for manual segmentation — one of the current “gold standards” of neurodegenerative disease detection.
Is reliable, actionable and timesaving
In as little as 10 minutes 45 of the most important brain structures are quantified.
The accurate data Neuroreader® provides can benefit the optimization of treatment.
Adds value
Quantitative volumetric imaging adds substantial diagnostic value to neuroimaging by providing objective evaluation of the MRI findings.
Incorporates easily into workflow
Neuroreader® is easy to add on to any routine MRI of the brain and to any existing workflow.
Neuroreader® – MRI volumetric analysis Software Is reliable, actionable and timesaving In as little as 10 minutes 45 of the
Här kommer det finnas text. Lång eller kort text men oavsett något som ska vara läsbart
Här kommer det finnas text. Lång eller kort text men oavsett något som ska vara läsbart
